This article only represents the author's own views.
Another day, another medical IPO.
That’s been a major theme for 2021 in Hong Kong, where a steady stream of drug and medical device makers have been marching to market throughout the year. The latest of those, MicroTech Medical (Hangzhou) Co. Ltd. (2235.HK), has been greeted with a relative yawn by investors, with its shares barely budging since their trading debut last week.
您已閱讀7%（429字），剩餘93%（5675字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。
